Detalles de la búsqueda
1.
Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival-a propensity score cohort study.
Breast Cancer Res Treat
; 206(1): 131-141, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38635082
2.
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.
Breast Cancer Res Treat
; 199(3): 445-456, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37043108
3.
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Breast Cancer Res Treat
; 185(3): 657-666, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068198
4.
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).
Front Oncol
; 13: 1184021, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37621686
5.
Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.
Ann Surg Oncol
; 17(3): 772-7, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20183912
6.
Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
Oncology
; 72(1-2): 27-32, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17998787
7.
Lymphoscintigraphy in oral squamous cell carcinoma sentinel node biopsy and its role in the surgical planning.
Clin Nucl Med
; 39(2): e142-5, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24097006
Resultados
1 -
7
de 7
1
Próxima >
>>